Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksSUVENPHAR
resources
SUVENPHAR

Cohance Lifesciences Ltd.

NSE: COHANCE
BSE: 543064
Sector: Healthcare
Industry: Pharmaceuticals
449.85-6.1 (-1.33%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Cohance Lifesciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Cohance Lifesciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General12 Oct 2026
    General Updates
    General updates
  2. Change in Management9 Oct 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Appointment of Mr. Abhimanyu Ojha as Chief Financial Officer of the Company
  3. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Compliance Certificate under 74(5) of SEBI (DP) Regulations 2018
  4. General6 Oct 2026
    ESG Rating By Crisil ESG Ratings & Analytics Limited
    ESG Rating by Crisil ESG ratings & Analytics Limited
  5. Closure of Trading Window28 Sept 2026
    Closure of Trading Window
    Closure of Trading Window
  6. General21 Sept 2026
    General Upadte
    General update
  7. General18 Sept 2026
    General Update
    General update
  8. AGM17 Sept 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Scrutinizer`s report
  9. AGM17 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Proceedings of Annual General Meeting
  10. Analyst / Investor Meet17 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Investor Meet
  11. General5 Sept 2026
    Completion Of USFDA Inspection
    Completion of USFDA Inspection
  12. Press Release / Media Release3 Sept 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release
  13. Outcome without intimation3 Sept 2026
    Board Meeting Outcome for Outcome Of The Committee Meeting
    Outcome of Committee Meeting
  14. Analyst / Investor Meet27 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Investors Meet
  15. Newspaper Publication27 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication
  16. Business Responsibility and Sustainability Reporting (BRSR)26 Aug 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    BRSR
  17. Reg. 34 (1) Annual Report26 Aug 2026
    Reg. 34 (1) Annual Report.
    Annual Report 2026
  18. AGM26 Aug 2026
    Notice Of AGM 2026
    Notice of AGM 2026
  19. Credit Rating13 Aug 2026
    Announcement under Regulation 30 (LODR)-Credit Rating
    Credit Rating
  20. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201112 Aug 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DSP Trustee Pvt Ltd

Frequently Asked Questions

Where can I download the annual report of Cohance Lifesciences Ltd.?
Annual reports of Cohance Lifesciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Cohance Lifesciences Ltd.?
Quarterly earnings results and presentations of Cohance Lifesciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Cohance Lifesciences Ltd. publish earnings call transcripts?
Earnings call transcripts of Cohance Lifesciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Cohance Lifesciences Ltd.?
Investor presentations and annual day presentations of Cohance Lifesciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Cohance Lifesciences Ltd.?
Corporate announcements and regulatory filings of Cohance Lifesciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Cohance Lifesciences Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Cohance Lifesciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Cohance Lifesciences Ltd.?
The ISIN (International Securities Identification Number) of Cohance Lifesciences Ltd. is INE03QK01018. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Cohance Lifesciences Ltd. listed?
Cohance Lifesciences Ltd. is listed on NSE and BSE. The NSE symbol is SUVENPHAR and the BSE code is -.
Where can I find the shareholding pattern of Cohance Lifesciences Ltd.?
The quarterly shareholding pattern of Cohance Lifesciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Cohance Lifesciences Ltd. on Sharpely?
Share price data for Cohance Lifesciences Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.